Abstract:Background:Early-stage diagnosis and treatment can improve survival rates of liver cancer patients. Dynamic contrast-enhanced MRI provides the most comprehensive information for differential diagnosis of liver tumors. However, MRI diagnosis is affected by subjective experience, so deep learning may supply a new diagnostic strategy. We used convolutional neural networks (CNNs) to develop a deep learning system (DLS) to classify liver tumors based on enhanced MR images, unenhanced MR images, and clinical data including text and laboratory test results. Methods:Using data from 1,210 patients with liver tumors (N= 31,608 images), we trained CNNs to get seven-way classifiers, binary classifiers, and three-way malignancy-classifiers (Model A-Model G). Models were validated in an external independent extended cohort of 201 patients (N= 6,816 images). The area under receiver operating characteristic (ROC) curve (AUC) were compared across different models. We also compared the sensitivity and specificity of models with the performance of three experienced radiologists. Results:Deep learning achieves a performance on par with three experienced radiologists on classifying liver tumors in seven categories. Using only unenhanced images, CNN performs well in distinguishing malignant from benign liver tumors (AUC, 0.946; 95% CI 0.914-0.979 vs. 0.951; 0.919-0.982,P= 0.664). New CNN combining unenhanced images with clinical data greatly improved the performance of classifying malignancies as hepatocellular carcinoma (AUC, 0.985; 95% CI 0.960-1.000), metastatic tumors (0.998; 0.989-1.000), and other primary malignancies (0.963; 0.896-1.000), and the agreement with pathology was 91.9%.These models mined diagnostic information in unenhanced images and clinical data by deep-neural-network, which were different to previous methods that utilized enhanced images. The sensitivity and specificity of almost every category in these models reached the same high level compared to three experienced radiologists. Conclusion:Trained with data in various acquisition conditions, DLS that integrated these models could be used as an accurate and time-saving assisted-diagnostic strategy for liver tumors in clinical settings, even in the absence of contrast agents. DLS therefore has the potential to avoid contrast-related side effects and reduce economic costs associated with current standard MRI inspection practices for liver tumor patients.

Deep Learning May Differentiate Head And Neck High-Grade Lymphomas.

Image-Based Deep Learning Detection of High-Grade B-Cell Lymphomas Directly from Hematoxylin and Eosin Images

Deep learning shows the capability of high-level computer-aided diagnosis in malignant lymphoma

Harnessing Deep Learning for Accurate Pathological Assessment of Brain Tumor Cell Types

Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data

Diagnosis of Malignant Lymphoma Cancer Using Hybrid Optimized Techniques Based on Dense Neural Networks

Deep learning analysis of mid-infrared microscopic imaging data for the diagnosis and classification of human lymphomas

Deep learning for image classification between primary central nervous system lymphoma and glioblastoma in corpus callosal tumors

Artificial Intelligence Analysis and Reverse Engineering of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using Gene Expression Data

Classification and Morphological Analysis of DLBCL Subtypes in H\&E-Stained Slides

Automated Diagnosis of Lymphoma with Digital Pathology Images Using Deep Learning

Deep Learning-Based Classification of Early-Stage Mycosis Fungoides and Benign Inflammatory Dermatoses on H&E-Stained Whole-Slide Images: A Retrospective, Proof-of-Concept Study

LymphoML: An interpretable artificial intelligence-based method identifies morphologic features that correlate with lymphoma subtype

Deriving Imaging Biomarkers for Primary Central Nervous System Lymphoma Using Deep Learning

Accurate diagnosis of lymphoma on whole-slide histopathology images using deep learning

Deep Learning for identifying radiogenomic associations in breast cancer

Deep learning-based classification of early-stage mycosis fungoides and benign inflammatory dermatoses on hematoxylin and eosin-stained whole-slide images: a retrospective, proof-of-concept study

Radt-12. Deriving Imaging Biomarkers For Primary Central Nervous System Lymphoma Using Deep Learning

Machine Learning and Deep Learning CT-Based Models for Predicting the Primary Central Nervous System Lymphoma and Glioma Types: A Multicenter Retrospective Study

Deep learning-based interpretable prediction of recurrence of diffuse large B-cell lymphoma

A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis and Primary Central Nervous System Lymphoma: A Pilot Study